fda banned tirzepatide says years-long shortage is resolved, will give limited leeway to compounders FDA Ban on Compounded GLP-1

This position has shifted multiple times in 2024-2026

Glutamates ability to bind to various types of receptors (i.e., ionotropic ligand-gated ion channels and metabotropic receptors, which modulate presynaptic glutamate release) means it is abundant and indispensable to normal brain function, as it contributes to the majority of excitatory processes (Chen et al., 2023

Variants in FTO , GLP1R (the GLP-1 receptor gene that every one of these compounds targets), MC4R , and TCF7L2 shape the metabolic terrain a clinician prescribes into

We'll cover it more on future podcasts

Standard protocol: 2 mg weekly, typically administered as two 1mg injections spaced 3 to 4 days apart